Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value: $318M (93.2% shares, 6.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | FIBROGEN INC | 1,216,473 | $37.07M | 11.6% | $24.72 | — | COM | 31572Q808 |
| — | FIVE PRIME THERAPEUTICS INC | 719,000 | $29.84M | 9.4% | $36.09 | — | COM | 33830X104 |
| — | JAZZ PHARMACEUTICALS | 189,200 | $26.59M | 8.4% | — | — | Call | G50871905 |
| — | RETROPHIN INC | 1,224,384 | $23.62M | 7.4% | $21.12 | — | COM | 761299106 |
| — | ARRAY BIOPHARMA INC | 22,534 | $21.63M | 6.8% | $0.96 | — | NOTE | 04269XAA3 |
| KURA | KURA ONCOLOGY INC | 2,450,000 | $20.58M | 6.5% | $10.42 | 0.0% | COM | 50127T109 |
| — | ASSEMBLY BIOSCIENCES INC | 2,098,302 | $15.76M | 4.9% | $9.53 | — | COM | 045396108 |
| CYTK | CYTOKINETICS INC | 1,418,700 | $14.84M | 4.7% | $9.81 | 0.0% | COM | 23282W605 |
| — | VALEANT PHARMACEUTICALS INTL | 126,500 | $12.86M | 4.0% | — | — | Call | 91911K902 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 465,118 | $12.79M | 4.0% | $17.29 | +21.8% | COM | 19459J104 |
| — | EPIZYME INC | 698,900 | $11.2M | 3.5% | $19.11 | — | COM | 29428V104 |
| GLPG | GALAPAGOS | 167,361 | $10.52M | 3.3% | $62.88 | — | SPONSORED ADR | 36315X101 |
| — | KITE PHARMA INC | 166,000 | $10.23M | 3.2% | $57.67 | — | COM | 49803L109 |
| — | FLEX PHARMA INC | 795,088 | $9.899M | 3.1% | $19.13 | — | COM | 33938A105 |
| IRWD | IRONWOOD PHARMACEUTICALS | 821,531 | $9.522M | 3.0% | $9.66 | 0.0% | COM CL A | 46333X108 |
| — | NABRIVA THERAPEUTICS AG | 838,680 | $7.931M | 2.5% | $9.50 | — | SPONSORED ADR | 62957M104 |
| — | ATYR PHARMA INC | 790,462 | $7.77M | 2.4% | $18.52 | — | COM | 002120103 |
| — | KINDRED BIOSCIENCES INC | 1,432,765 | $4.871M | 1.5% | $7.10 | — | COM | 494577109 |
| — | RETROPHIN INC | 244,100 | $4.709M | 1.5% | — | — | Call | 761299906 |
| — | CELLADON CORP | 2,843,170 | $4.179M | 1.3% | $1.26 | — | COM | 15117E107 |
| — | OVASCIENCE INC | 424,979 | $4.152M | 1.3% | $9.77 | — | COM | 69014Q101 |
| — | GENVEC INC | 1,920,913 | $3.534M | 1.1% | $2.08 | — | COM | 37246C307 |
| — | CALITHERA BIOSCIENCES INC | 415,480 | $3.183M | 1.0% | $15.57 | — | COM | 13089P101 |
| — | CYTOKINETICS INC | 284,600 | $2.977M | 0.9% | — | — | Call | 23282W905 |
| — | ZAFGEN INC | 369,000 | $2.321M | 0.7% | $6.29 | — | COM | 98885E103 |
| — | FORWARD PHARMA A/S | 100,017 | $1.9M | 0.6% | $23.61 | — | SPONSORED ADR | 34986J105 |
| — | AKARI THERAPEUTICS PLC | 100,750 | $1.461M | 0.5% | $24.00 | — | SPONSORED ADR | 00972G108 |
| — | GILEAD SCIENCES INC | 11,800 | $1.194M | 0.4% | — | — | Call | 375558903 |
| — | NEPHROGENEX INC | 588,235 | $941K | 0.3% | $1.60 | — | COM | 640667101 |
| — | QLT INC | 100,000 | $266K | 0.1% | $3.58 | — | COM | 746927102 |
| — | ZAFGEN INC | 10,000 | $63,000 | 0.0% | — | — | Call | 98885E903 |